Select Medical's (SEM) "Sell (D+)" Rating Reaffirmed at Weiss Ratings

Key Points

• Select Medical's stock is reaffirmed with a "Sell (D+)" rating by Weiss Ratings, despite mixed analyst opinions.
• Bank of America lowered its price target for Select Medical from $18.00 to $15.00, while Royal Bank Of Canada increased it from $16.00 to $20.00.
• The company reported a quarterly EPS of $0.32, exceeding analyst expectations, yet its revenue of $1.34 billion fell slightly short of forecasts.

Select Medical (NYSE:SEM - Get Free Report)'s stock had its "sell (d+)" rating reissued by Weiss Ratings in a research note issued on Wednesday,Weiss Ratings reports.

A number of other analysts have also recently issued reports on SEM. Bank of America reduced their price objective on shares of Select Medical from $18.00 to $15.00 and set a "buy" rating for the company in a research note on Wednesday, September 10th. UBS Group reaffirmed a "neutral" rating and set a $14.00 target price (down from $15.00) on shares of Select Medical in a research note on Monday, August 4th. Finally, Royal Bank Of Canada raised their target price on shares of Select Medical from $16.00 to $20.00 and gave the company an "outperform" rating in a research note on Wednesday. Four investment analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $19.40.

Select Medical Stock Performance

Shares of NYSE:SEM traded up $1.21 during midday trading on Wednesday, hitting $14.25. The company had a trading volume of 3,882,147 shares, compared to its average volume of 1,150,671. The company has a fifty day moving average of $12.76 and a two-hundred day moving average of $14.54. The company has a debt-to-equity ratio of 0.92, a current ratio of 1.15 and a quick ratio of 1.15. The company has a market cap of $1.77 billion, a price-to-earnings ratio of 13.44, a PEG ratio of 0.53 and a beta of 1.28. Select Medical has a 12-month low of $11.65 and a 12-month high of $40.98.

Select Medical (NYSE:SEM - Get Free Report) last announced its quarterly earnings data on Thursday, July 31st. The health services provider reported $0.32 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.28 by $0.04. The firm had revenue of $1.34 billion during the quarter, compared to analysts' expectations of $1.35 billion. Select Medical had a net margin of 2.37% and a return on equity of 8.87%. The company's revenue for the quarter was up 4.5% compared to the same quarter last year. During the same period in the prior year, the company posted $0.60 earnings per share. Select Medical has set its FY 2025 guidance at 1.090-1.19 EPS. On average, equities research analysts expect that Select Medical will post 1.17 EPS for the current fiscal year.

Institutional Investors Weigh In On Select Medical

Institutional investors have recently made changes to their positions in the company. MAI Capital Management lifted its holdings in shares of Select Medical by 48,000.0% in the 2nd quarter. MAI Capital Management now owns 2,405 shares of the health services provider's stock worth $37,000 after acquiring an additional 2,400 shares during the last quarter. Caitong International Asset Management Co. Ltd lifted its holdings in shares of Select Medical by 61.6% in the 1st quarter. Caitong International Asset Management Co. Ltd now owns 2,703 shares of the health services provider's stock worth $45,000 after acquiring an additional 1,030 shares during the last quarter. BI Asset Management Fondsmaeglerselskab A S bought a new stake in shares of Select Medical in the 1st quarter worth about $60,000. Advisors Asset Management Inc. lifted its holdings in shares of Select Medical by 168.2% in the 1st quarter. Advisors Asset Management Inc. now owns 6,301 shares of the health services provider's stock worth $105,000 after acquiring an additional 3,952 shares during the last quarter. Finally, GAMMA Investing LLC lifted its holdings in shares of Select Medical by 217.4% in the 1st quarter. GAMMA Investing LLC now owns 6,501 shares of the health services provider's stock worth $109,000 after acquiring an additional 4,453 shares during the last quarter. Institutional investors own 89.48% of the company's stock.

About Select Medical

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.